Replies to post #239260 on Biotech Values

[DewDiligence]

There's some risk the deal won't go through. The deal requires approval from a 2/3 majority of TRIL shareholders.

[bladerunner1717]

Oakes,

I was wondering the same thing.

Bladerunner

[jbog]

My impression is that it's trading about 4.5% below the offer because of the undefined closing date.

It doesn't seem out of line in my view.